AOR
Archives of Ophthalmological Research

The Archives of Ophthalmological Research aims to publish issues related to publish articles of the highest scientific and clinical value at an international level, and accepts articles on these topics. The target audience of the journal included specialists and physicians working in ophthalmology, and other health professionals interested in these fields.

eISSN: 3023-6479
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Short-term results of steroid treatment in patients with non-arteritic ischemic optic neuropathy
Abstract
Aims: To evaluate the effects of steroid treatment on the best-corrected visual acuity (BCVA) and retinal nerve fiber layer (RNFL) in patients with non-arteritic ischemic optic neuropathy (NAION).
Methods: The retrospective study included 24 eyes of 24 patients who received 1 gram/day pulse steroid treatment for 3 days with a diagnosis of NAION. The patient's comorbidities, demographic information, intraocular pressure, BCVA, and RNFL measured by optical coherence tomography (OCT) were recorded before and after treatment at one month.
Results: The mean age of the patients was 64.35±14.6 (22-86). Diabetes mellitus was present in 14 patients (58.3%), hypertension in 13 (54.2%), and coronary artery disease in 5 (27.8%). The pre-treatment BCVA was 0.33±0.37, and post-treatment BCVA was 0.37±0.36 (p=0.345). The pre-treatment RNFL value was 208.0±57.9, and the post-treatment RNFL value was 113.6±32.6 (p<0.000). No additional complications related to treatment were observed.
Conclusion: While there was no significant difference in BCVA values one month after steroid treatment, a significant anatomical improvement was observed in RNFL thickness.

Keywords : Non-arteritic ischemic optic neuropathy, pulse steroid, retinal nerve fiber layer

Download Article


1. Espino Barros A, Amram AL, Derham AM, Smith SV, Lee AG. Management of ischemic optic neuropathies. <em>Exp Rev Ophthalmol.</em> 2017;12(2):99-109.
2. Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. <em>Am J Ophthalmol.</em> 1997;123(1):103-107. doi:10.1016/s0002-9394(14)70999-7
3. Reis AS, Sharpe GP, Yang H, Nicolela MT, Burgoyne CF, Chauhan BC. Optic disc margin anatomy in patients with glaucoma and normal controls with spectral domain optical coherence tomography. <em>Ophthalmology.</em> 2012;119(4):738-747. doi:10.1016/j.ophtha.2011.09.054
4. Lee MS, Grossman D, Arnold AC, Sloan FA. Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients. <em>Ophthalmology.</em> 2011;118(5):959-963. doi:10.1016/j.ophtha. 2011.01.054
5. Hayreh SS, Joos KM, Podhajsky PA, Long CR. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy. <em>Am J Ophthalmol.</em> 1994;118(6):766-780. doi:10.1016/s0002-9394(14)72557-7
6. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nonarteritic anterior ischemic optic neuropathy: role of nocturnal arterial hypotension. <em>Arch Ophthalmol.</em> 1997;115(7):942-945. doi:10.1001/archopht.1997.01100160112031
7. Wu Y, Zhou LM, Lou H, Cheng JW, Wei RL. The association between obstructive sleep apnea and nonarteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis. <em>Curr Eye Res.</em> 2016; 41(7):987-992. doi:10.3109/02713683.2015.1075221
8. Al-Zubidi N, Zhang J, Spitze A, Lee AG. Systemic corticosteroids in nonarteritic ischemic optic neuropathy. <em>Indian J Ophthalmol.</em> 2014; 62(10):1022-1024. doi:10.4103/0301-4738.146015
9. Mathews MK. Nonarteritic anterior ischemic optic neuropathy. <em>Curr Opin Ophthalmol.</em> 2005;16(6):341-345. doi:10.1097/01.icu.0000188361. 52166.93
10. Sch&ouml;nfeld CL, Fischer M, Distelmaier P, et al. Recovery of visual function after administration of dabigatran etexilate. <em>Case Rep Ophthalmol.</em> 2014;5(2):262-266. doi:10.1159/000365961
11. Danylkova NO, Alcala SR, Pomeranz HD, McLoon LK. Neuroprotective effects of brimonidine treatment in a rodent model of ischemic optic neuropathy. <em>Exp Eye Res.</em> 2007;84(2):293-301. doi:10. 1016/j.exer.2006.10.002
12. Prescott CR, Sklar CA, Lesser RL, Adelman RA. Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy?. <em>J Neuroophthalmol.</em> 2012;32(1):51-53. doi: 10.1097/WNO.0b013e318240596e
13. Hayreh SS, Zimmerman MB. Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy. <em>Graefes Arch Clin Exp Ophthalmol.</em> 2008;246(7):1029-1046. doi:10.1007/s00417-008-0805-8
14. Hayreh SS. Management of ischemic optic neuropathies. <em>Indian J Ophthalmol.</em> 2011;59(2):123-136. doi:10.4103/0301-4738.77024
15. Takayama K, Kaneko H, Kachi S, Ra E, Ito Y, Terasaki H. High-dose intravenous pulse steroid therapy for optic disc swelling and subretinal fluid in non-arteritic anterior ischemic optic neuropathy. <em>Nagoya J Med Sci.</em> 2017;79(1):103-108. doi:10.18999/nagjms.79.1.103
16. Rebolleda G, P&eacute;rez-L&oacute;pez M, Casas-LLera P, Contreras I, Mu&ntilde;oz-Negrete FJ. Visual and anatomical outcomes of non-arteritic anterior ischemic optic neuropathy with high-dose systemic corticosteroids. <em>Graefes Arch Clin Exp Ophthalmol.</em> 2013;251(1):255-260. doi:10.1007/s00417-012-1995-7
Article available in :
Volume 1, Issue 4, 2024
Page : 72-74
https://doi.org/10.51271/AOR-0020
Article Information
Received : 15 Eyl 2024
Accepted : 17 Eki 2024
Published : 23 Eki 2024
Corresponding Author :

Melek Kaya: Department of Ophthalmology, Faculty of Medicine, Tokat Gaziosmanpaşa University Tokat, Turkiye

[email protected]
Citation : Kaya M, Konuk ŞG, Kılıç R. Short-term results of steroid treatment in patients with non-arteritic ischemic optic neuropathy. Arch Ophthalmol Res. 2024;1(4):72-74.

Read: 193
Download : 630
Cited: 0
_Footer